Cargando…
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Patients with blood disorders who are immune suppressed are at increased risk for infection with severe acute respiratory syndrome coronavirus 2. Sequelae of infection can include severe respiratory disease and/or prolonged duration of viral shedding. Cellular therapies may protect these vulnerable...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896869/ https://www.ncbi.nlm.nih.gov/pubmed/35240679 http://dx.doi.org/10.1182/blood.2021012249 |